作者:Igor D. Jurberg、Bo Peng、Eckhard Wöstefeld、Maximilian Wasserloos、Nuno Maulide
DOI:10.1002/anie.201108639
日期:2012.2.20
Sacrifice for the team: A one‐pot method achieves remote functionalization at the α‐position of an amine moiety through the sacrificial reduction of a neighboring group. The process takes advantage of an intramolecular redox reaction, thereby avoiding the need for any external oxidants. This method was applied to a concise five‐step total synthesis of indolizidine 167B.
Bispidine compounds useful in the treatment of cardiac arrythmias
申请人:AstraZeneca AB
公开号:US20040229900A1
公开(公告)日:2004-11-18
There is provided compounds of formula I,
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
41
, R
42
, R
43
R
44
, R
45
, R
46
, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
Modified Julia Olefination on Pyrrolidinone: Application to the Total Synthesis of Indolizidine 209D
作者:Bastien Raison、Nicolas Dussart、David Gueyrard
DOI:10.1002/ejoc.202200334
日期:2022.7.21
The olefination of Boc-protected lactams was extended to pyrrolidinone using a modifiedJuliaolefination. We also demonstrates that exo-enamides can be easily transformed into indolizidine and this methodology was applied to the total synthesis of natural Indolizidine 209D.
使用改进的 Julia 烯化将 Boc 保护的内酰胺的烯化扩展到吡咯烷酮。我们还证明了外-烯酰胺可以很容易地转化为吲哚里西啶,并且该方法应用于天然吲哚里西啶 209D 的全合成。
BISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS
申请人:AstraZeneca AB
公开号:EP1192157A1
公开(公告)日:2002-04-03
[EN] NEW BISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS<br/>[FR] NOUVEAUX COMPOSES DE BISPIDINE UTILES DANS LE TRAITEMENT DES ARYTHMIES CARDIAQUES
申请人:ASTRAZENECA AB
公开号:WO2000077000A1
公开(公告)日:2000-12-21
There is provided compounds of formula (I), wherein R?1, R2, R3, R4, R5, R6, R7, R41, R42, R43, R44, R45, R46¿, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.